| 15/07/22 | 07:00:05 | 15 Jul 2022 | | Issue of shares pursuant to incentive scheme | RNS |
| 11/07/22 | 07:00:06 | 11 Jul 2022 | | Freeline presents data in haemophilia B | RNS |
| 07/07/22 | 09:41:24 | 7 Jul 2022 | | Holding(s) in Company | RNS |
| 30/06/22 | 09:00:11 | 30 Jun 2022 | | Publication of 2022 Annual Report & Notice of AGM | RNS |
| 22/06/22 | 17:21:27 | 22 Jun 2022 | | Director Declaration | RNS |
| 16/06/22 | 07:00:06 | 16 Jun 2022 | | Final Results | RNS |
| 10/06/22 | 08:05:06 | 10 Jun 2022 | | Autolus presents clinical data updates at EHA | RNS |
| 08/06/22 | 14:33:06 | 8 Jun 2022 | | Holding(s) in Company | RNS |
| 19/05/22 | 07:00:13 | 19 May 2022 | | Notice of Results | RNS |
| 18/05/22 | 11:05:03 | 18 May 2022 | | Syncona invests in $56 million SwanBio Series B | RNS |
| 12/05/22 | 16:00:20 | 12 May 2022 | | Autolus to present clinical data at EHA Congress | RNS |
| 11/05/22 | 07:00:05 | 11 May 2022 | | Freeline reports Q1 2022 Financial Results | RNS |
| 10/05/22 | 13:02:51 | 10 May 2022 | | Achilles reports Q1 2022 Financial Results | RNS |
| 05/05/22 | 12:05:06 | 5 May 2022 | | Autolus Reports Q1 2022 Financial Results | RNS |
| 28/04/22 | 07:00:12 | 28 Apr 2022 | | Syncona invests in £75.5 million OMass Series B | RNS |
| 11/04/22 | 07:00:09 | 11 Apr 2022 | | Anaveon announces initial clinical data | RNS |
| 04/04/22 | 12:34:35 | 4 Apr 2022 | | Director/PDMR Shareholding | RNS |
| 01/04/22 | 07:00:09 | 1 Apr 2022 | | Freeline reports Full Year 2021 Financial Results | RNS |
| 24/03/22 | 16:11:03 | 24 Mar 2022 | | Holding(s) in Company | RNS |
| 23/03/22 | 08:30:02 | 23 Mar 2022 | | Freeline enters into ADS purchase agreement | RNS |
| 11/03/22 | 07:00:05 | 11 Mar 2022 | | Freeline registered direct offering | RNS |
| 10/03/22 | 12:05:02 | 10 Mar 2022 | | Autolus Reports Full Year 2021 Financial Results | RNS |
| 09/03/22 | 16:39:31 | 9 Mar 2022 | | Director/PDMR Shareholding | RNS |
| 09/03/22 | 15:09:28 | 9 Mar 2022 | | Holding(s) in Company | RNS |
| 07/03/22 | 17:29:56 | 7 Mar 2022 | | Director/PDMR Shareholding | RNS |
| 01/03/22 | 12:56:00 | 1 Mar 2022 | | Achilles reports Full Year 2021 Results | RNS |
| 18/02/22 | 07:00:09 | 18 Feb 2022 | | Completion of sale of Gyroscope Therapeutics | RNS |
| 10/02/22 | 07:00:02 | 10 Feb 2022 | | 3rd Quarter Results | RNS |
| 08/02/22 | 12:05:04 | 8 Feb 2022 | | Freeline presents data in Fabry disease | RNS |
| 31/12/21 | 07:00:04 | 31 Dec 2021 | | Directorate Change | RNS |
| 22/12/21 | 07:00:06 | 22 Dec 2021 | | Gyroscope to be acquired for up to $1.5 billion | RNS |
| 16/12/21 | 07:00:07 | 16 Dec 2021 | | Syncona cornerstones Anaveon Series B | RNS |
| 14/12/21 | 07:00:07 | 14 Dec 2021 | | Freeline reports 2022 priorities and guidance | RNS |
| 13/12/21 | 14:05:07 | 13 Dec 2021 | | Freeline presents data in haemophilia B | RNS |
| 13/12/21 | 12:05:08 | 13 Dec 2021 | | Autolus presents positive AUTO1 (obe-cel) data | RNS |
| 29/11/21 | 07:00:08 | 29 Nov 2021 | | Syncona co-leads Series B financing in Quell | RNS |
| 22/11/21 | 07:00:09 | 22 Nov 2021 | | Syncona appoints new Directors | RNS |
| 12/11/21 | 13:56:33 | 12 Nov 2021 | | Achilles Presents Data at the SITC Annual Meeting | RNS |
| 11/11/21 | 07:00:02 | 11 Nov 2021 | | Half-year Report | RNS |
| 10/11/21 | 07:00:06 | 10 Nov 2021 | | Freeline reports new data and 3rd Quarter Results | RNS |
| 09/11/21 | 13:31:21 | 9 Nov 2021 | | Achilles reports Third Quarter Financial Results | RNS |
| 08/11/21 | 13:05:01 | 8 Nov 2021 | | Gyroscope Announces Sanofi Equity Investment | RNS |
| 08/11/21 | 07:00:09 | 8 Nov 2021 | | Blackstone Life Science to invest $250m in Autolus | RNS |
| 03/11/21 | 11:07:02 | 3 Nov 2021 | | Syncona leads $87 million financing of Clade | RNS |
| 03/11/21 | 11:05:02 | 3 Nov 2021 | | Autolus reports Q3 2021 Financial Results | RNS |
| 26/10/21 | 07:00:05 | 26 Oct 2021 | | Notice of Results | RNS |
| 30/09/21 | 15:59:18 | 30 Sept 2021 | | Gyroscope announces additional positive data | RNS |
| 17/08/21 | 07:00:03 | 17 Aug 2021 | | First Quarter Update | RNS |
| 16/08/21 | 12:07:02 | 16 Aug 2021 | | Freeline Reports Executive Change and Q2 Results | RNS |
